John M. Maraganore
2016
In 2016, John M. Maraganore earned a total compensation of $1.7M as Chief Executive Officer principal executive officer at Alnylam Pharmaceuticals, a 79% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $380,432 |
|---|---|
| Option Awards | $620,958 |
| Salary | $731,600 |
| Other | $11,852 |
| Total | $1,744,842 |
Maraganore received $731.6K in salary, accounting for 42% of the total pay in 2016.
Maraganore also received $380.4K in non-equity incentive plan, $621K in option awards and $11.9K in other compensation.
Rankings
In 2016, John M. Maraganore's compensation ranked 5,524th out of 14,075 executives tracked by ExecPay. In other words, Maraganore earned more than 60.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,524 out of 14,075 | 61st |
Division Manufacturing | 1,988 out of 5,488 | 64th |
Major group Chemicals And Allied Products | 634 out of 1,900 | 67th |
Industry group Drugs | 475 out of 1,543 | 69th |
Industry Pharmaceutical Preparations | 377 out of 1,173 | 68th |
Source: SEC filing on March 23, 2018.
Maraganore's colleagues
We found five more compensation records of executives who worked with John M. Maraganore at Alnylam Pharmaceuticals in 2016.
2016
Yvonne Greenstreet
Alnylam Pharmaceuticals
Chief Operating Officer
2016
Akshay Vaishnaw
Alnylam Pharmaceuticals
President, Research and Development
2016
Barry Greene
Alnylam Pharmaceuticals
President
2016
David-Alexandre Gros
Alnylam Pharmaceuticals
Former Senior Vice President, Chief Business Officer former principal financial officer
2016
Michael Mason
Alnylam Pharmaceuticals